Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Tablet Health vs Trava Health

Tablet Health
Graded #495

Lower grade

vs+20.999999999999993
Trava Health
Graded #146

Higher grade

The verdict

Trava Health takes it — 68.6/100 to 47.6/100.

Trava Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Houston-based DTC telehealth offering compounded semaglutide+B12 and tirzepatide+B12 through SIX named 503A compounding pharmacy partners disclosed on Trava's own Terms + Telehealth Consent pages…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTrava Health +35
45
80
Dose & formulationTrava Health +13
51
64
Clinical oversightTrava Health +32
37
69
Labs & monitoringTrava Health +2
50
52
FulfillmentTrava Health +25
57
82
Contract termsEven
55
55
Tablet Health · left barTrava Health · right bar

The numbers

MetricTablet HealthTrava Health
WeighScore47.6/10068.6/100
GradeCC
Scorecard rank#495#146
SemaglutideNot disclosed$119/mo (starting dose, compounded)
TirzepatideNot disclosed$198/mo (starting dose, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Tablet Health

Graded #495 · C

Strengths

  • LegitScript Certified
  • Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
  • Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
  • Mid-tier pricing starting $179–$299/mo across all four product variants
  • No commitment — cancel anytime

Where it loses points

  • States served not published — you must complete the intake quiz to learn eligibility
  • No founder, CEO, medical director, or pharmacist-in-charge named anywhere
  • No BBB profile found
  • Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
Trava Health

Graded #146 · C

Strengths

  • Six named compounding pharmacy partners disclosed in 3rd-party reviews
  • Independent batch testing by Eagle Analytical (FDA-registered lab)
  • Free overnight shipping included
  • No membership fee — pay only for medication
  • HSA/FSA eligible

Where it loses points

  • No LegitScript accreditation badge surfaced
  • BBB F rating with 2 unanswered complaints (BBB file opened 2025-07-07)
  • Clinician roster page returns 404 — no public team listing
  • Founder/CEO not publicly named on site
  • Higher dose pricing gated behind questionnaire (not transparent on public page)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard